- Home
- NAGE
NAGE
Niagen Bioscience Inc. Common Stock
as 04-18-2025 1:40pm EST
| Founded: | 1999 | Country: | United States |
| Employees: | N/A | City: | N/A |
| Market Cap: | 594.0M | IPO Year: | N/A |
| Target Price: | $11.00 | AVG Volume (30 days): | 665.7K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.11 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.31 - $9.18 | Next Earning Date: | 05-07-2025 |
| Revenue: | $99,597,000 | Revenue Growth: | 19.18% |
| Revenue Growth (this year): | 21.53% | Revenue Growth (next year): | 20.87% |
Latest Niagen Bioscience Inc. Common Stock News
NAGE Breaking Stock News: Dive into NAGE Ticker-Specific Updates for Smart Investing
Business Wire
11 days ago
Niagen Bioscience Confirms Its Operations Remain Unaffected by New Tariffs
Simply Wall St.
16 days ago
Growth Companies With High Insider Ownership For April 2025
Simply Wall St.
24 days ago
A Look At The Fair Value Of Niagen Bioscience, Inc. (NASDAQ:NAGE)
Insider Monkey
25 days ago
Why ChromaDex Corp (CDXC) Is Surging In 2025?
Compare NAGE vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "NAGE Niagen Bioscience Inc. Common Stock - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.